The advent of antiretroviral therapy has radically changed the prognosis of human immunodeficiency virus (HIV) infection. HIV is now a treatable medical condition and is increasingly managed as a chronic disease. The majority of those living with the virus remain fit and well on treatment. However, those living with HIV are at risk of adverse effects due to antiretroviral treatment and increased risk of cardiovascular disease.
Get full access to this article
View all access options for this article.
References
1.
British HIV Association. British HIV Association, BASHH and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection (2008) British HIV Association Accessed via www.bhiva.org/UKGuidelines2008.aspx [date last accessed 31.12.2010].
GazzardB.G. BHIVA Treatment Guidelines Writing Group. British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Medicine (2008) 9: p. 563–608. Accessed via www.bhiva.org/TreatmentofHIV1_2008.aspx [date last accessed 31.12.2010].
5.
GerettiA.M.BrookG.British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Medicine (2008) 9 (10): p. 795–848. Accessed via www.bhiva.org/Immunization2008.aspx [date last accessed 31.12.2010].
Joint British Societies. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart200591 (suppl 5):v1–52.
